MetLife, Inc.

NYSE:MET 株式レポート

時価総額：US$56.2b

MetLife 過去の業績

過去 基準チェック /16

MetLifeの収益は年間平均-8%の割合で減少していますが、 Insurance業界の収益は年間 増加しています。収益は年間14.6% 1.9%割合で 増加しています。 MetLifeの自己資本利益率は13%であり、純利益率は4.4%です。

主要情報

-8.02%

収益成長率

-1.48%

EPS成長率

Insurance 業界の成長8.02%
収益成長率1.87%
株主資本利益率13.00%
ネット・マージン4.43%
前回の決算情報31 Mar 2026

最近の業績更新

Recent updates

分析記事 • 22h

MetLife (MET) Stock Could Be 47% Below Fair Value After New Settlement Product

MetLife’s new deferred payment solution puts product design in focus MetLife (MET) recently introduced the Non-Qualified Assignment Flex Agreement, or NQA-FA, a deferred payment solution that gives attorneys and brokers more control over the timing and structure of non-physical injury settlements. The NQA-FA uses a funding agreement rather than an annuity and supports features such as deferred start dates, lump sums and customized payment schedules, potentially broadening how MetLife stock...
ナラティブの更新 • Jun 09

MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance

Analysts have raised their price target on MetLife to $92.80 from $89.31, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E estimates. What's in the News MetLife reported Q1 2026 adjusted earnings growth of 18% year over year, with broad top line growth across all operating segments and resilient margins, supported by expanding businesses in Asia, Latin America, Group Benefits, and Retirement and Income Solutions.
Seeking Alpha • Jun 08

MetLife: Not Exciting, But It Works

Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking Alpha
ナラティブの更新 • May 03

MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential

Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.
ナラティブの更新 • Apr 17

MET: Share Repurchases Following Index Exit Will Support Future Upside Potential

Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).
ナラティブの更新 • Apr 01

MET: Share Repurchases And Index Exit Will Shape Future Upside Potential

Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.
ナラティブの更新 • Mar 18

MET: Share Repurchases Will Support Future Upside Potential

Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).
ナラティブの更新 • Mar 04

MET: Buybacks And Retirement Income Agreements Will Drive Future Upside

Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.
ナラティブの更新 • Dec 16

MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power

Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.
ナラティブの更新 • Nov 07

MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements

Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.
ナラティブの更新 • Oct 24

Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.
ナラティブの更新 • Oct 09

International Demand And Digital Transformation Will Fuel Success

Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.
ナラティブの更新 • Sep 04

International Demand And Digital Transformation Will Fuel Success

With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.
Seeking Alpha • Feb 11

MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart

Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential

Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Sep 23

MetLife: One Of The Best Life Insurance Stocks

Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking Alpha
Seeking Alpha • Jul 09

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking Alpha
Seeking Alpha • Jun 26

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking Alpha

収支内訳

MetLife の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NYSE:MET 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 2677,5843,43400
31 Dec 2577,0793,17300
30 Sep 2571,9323,63400
30 Jun 2573,0114,09100
31 Mar 2573,4944,30500
31 Dec 2470,9824,22600
30 Sep 2471,3403,56100
30 Jun 2468,7672,70800
31 Mar 2467,5702,16600
31 Dec 2366,9011,38000
30 Sep 2363,4792,35500
30 Jun 2369,8963,03100
31 Mar 2368,7473,54200
31 Dec 2268,7645,09900
30 Sep 2273,2514,72600
30 Jun 2267,8735,14900
31 Mar 2270,9237,63400
31 Dec 2168,6886,65400
30 Sep 2170,4095,30100
30 Jun 2169,5194,41300
31 Mar 2165,0941,11500
31 Dec 2067,8425,19100
30 Sep 2065,5675,60300
30 Jun 2068,2307,12200
31 Mar 2071,6288,73800
31 Dec 1969,6205,72100
30 Sep 1968,1397,19500
30 Jun 1965,7505,92300
31 Mar 1969,4385,08400
31 Dec 1867,9414,98200
30 Sep 1868,1125,244-2520
30 Jun 1867,9805,235-1660
31 Mar 1862,1195,19700
31 Dec 1762,3084,89300
30 Sep 1759,2631,893-330
30 Jun 1758,9082,044-280
31 Mar 1757,2632,229-970
31 Dec 1660,7323,48100
30 Sep 1665,2094,9943680
30 Jun 1667,2555,1693550
31 Mar 1669,9525,2193420
31 Dec 1561,2573,89100
30 Sep 1571,8885,8573330
30 Jun 1572,6776,7243500

質の高い収益: METは 高品質の収益 を持っています。

利益率の向上: METの現在の純利益率 (4.4%)は、昨年(5.9%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: METの収益は過去 5 年間で年間8%減少しました。

成長の加速: METは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: METは過去 1 年間で収益成長率がマイナス ( -20.2% ) となったため、 Insurance業界平均 ( 36.5% ) と比較することが困難です。

株主資本利益率

高いROE: METの 自己資本利益率 ( 13% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/06/17 21:53
終値2026/06/17 00:00
収益2026/03/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

MetLife, Inc. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31

アナリスト機関
Jacob KilsteinArgus Research Company
Jay GelbBarclays
Taylor ScottBarclays